Compare · CTSH vs GDRX
CTSH vs GDRX
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and GoodRx Holdings Inc. (GDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTSH and GDRX operate in EDP Services (Technology), so they compete in similar markets.
- CTSH is the larger of the two at $29.63B, about 24.8x GDRX ($1.20B).
- Over the past year, CTSH is down 0.1% and GDRX is down 12.4% - CTSH leads by 12.3 points.
- CTSH has been more active in the news (13 items in the past 4 weeks vs 3 for GDRX).
- Both have 25 recent analyst ratings on file.
- Company
- Cognizant Technology Solutions Corporation
- GoodRx Holdings Inc.
- Price
- -
- -
- Market cap
- $29.63B
- $1.20B
- 1M return
- +6.71%
- -1.18%
- 1Y return
- -0.08%
- -12.39%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- 2020
- News (4w)
- 13
- 3
- Recent ratings
- 25
- 25
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Latest CTSH
- 80% of Employees Want to Use AI More Than Their Jobs Allow
- SEC Form 8-K filed by Cognizant Technology Solutions Corporation
- Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
- Belcan Receives Pratt & Whitney Premier Awards for Overall Excellence in Business Management and Technology & Innovation
- Cognizant Selected by SITA to Deliver AI-Led Global Finance Transformation on the Cloud
- SEC Form 4 filed by Cognizant Technology Solutions Corporation
- Cognizant Launches Cognizant Activate to Bring Enterprise AI Transformation for Emerging Enterprises
- SVP, Controller & CAO Kerdman Alina sold $7,906 worth of shares (139 units at $56.88) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 1,124 units (SEC Form 4)
- Cognizant Schedules Third Quarter 2026 Earnings Release and Conference Call
- Cognizant Named to Forbes World's Best Employers 2026 List
Latest GDRX
- SEC Form 4 filed by GoodRx Holdings Inc.
- SEC Form 4 filed by GoodRx Holdings Inc.
- SEC Form 4 filed by GoodRx Holdings Inc.
- Chief Accounting Officer Chan Thomas (Tc) converted options into 2,101 shares and covered exercise/tax liability with 1,069 shares, increasing direct ownership by 8% to 14,578 units (SEC Form 4)
- Officer Fengler Justin converted options into 3,087 shares and covered exercise/tax liability with 1,354 shares, increasing direct ownership by 3% to 52,509 units (SEC Form 4)
- From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
- Amendment: SEC Form SCHEDULE 13D/A filed by GoodRx Holdings Inc.
- Large owner Francisco Partners Iv, L.P. sold $5,477,482 worth of shares (1,567,044 units at $3.50) (SEC Form 4)
- Large owner Francisco Partners Iv, L.P. converted options into 7,500,000 shares, disposed of 4,739,005 shares and sold $4,201,230 worth of shares (1,193,951 units at $3.52) (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.